Dan P. Zandberg
Papers
1
Total Citations
12
H-Index
1
About
Dr. Dan P. Zandberg is a leading oncologist and researcher specializing in head and neck cancers, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCC) and the long-term quality of life (QOL) outcomes of its treatment. His work critically examines the trade-offs between aggressive multimodal therapies—such as radiation and transoral robotic surgery—and their impact on patient well-being, including swallowing function and overall QOL. In a highly cited 2021 study, Dr. Zandberg analyzed a cross-section of advanced-stage OPSCC patients from his Survivorship Clinic, revealing key treatment factors that influence post-therapy QOL. This research, with 12 citations, underscores his commitment to patient-centered outcomes in survivorship care. Beyond this, Dr. Zandberg’s contributions extend to clinical trials and translational research aimed at improving therapeutic efficacy while minimizing toxicity. His work has shaped how clinicians balance curative intent with functional preservation, making him a pivotal voice in head and neck oncology. For students and researchers, Dr. Zandberg exemplifies the integration of rigorous clinical investigation with compassionate, real-world patient care.
Research Focus
Key Achievements
Top Papers
- 1